The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs.
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Interleukin-12 (IL-12) plays a key role in promoting T helper 1 (Th1) responses and subsequent cell-mediated immunity. Given the role of cytokines in the pathogenesis of psychiatric disorders, the dysregulation of IL-12 in these illnesses would be expected. We measured the plasma levels of IL-12 in 102 psychiatric patients (43 schizophrenia, 34 major depression and 25 bipolar disorder) and 85 normal controls. In addition, IL-12 levels of the patients were measured after an 8-week treatment to assess whether the levels were affected by medication. The IL-12 levels of the patient group with major depression were significantly higher than that of the control group, whereas no differences were found among the other groups. IL-12 values of the three patient groups decreased significantly after 8 weeks of treatment. These findings support the hypothesis that activation of the inflammatory response system and in particular of Th-1-like cells, is involved in the pathophysiology of major depression and that repeated administration of antidepressive and antipsychotic drugs may suppress IL-12 plasma concentrations in psychiatric patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated pro-inflammatory cytokines had been reported to be associated with greater symptom burden in BD (14, 15), and correlation between severity of affective symptoms and serum levels of IL-6, sIL-2R, sIL-6R, TNF-α and tumor necrosis factor receptor 60 and 80 kDa (sTNFR60/80) was found in several studies (16–21).”
From Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder? (2023) · cites this paper as [19]
In the citing paper
“there was a significant decrease in IL-12 plasma levels after eight weeks of antidepressant pharmacotherapy [118].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [118]
In the citing paper
“the plasma levels of IL-12 were significantly higher in patients with depression compared to controls”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [118]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Trinchieri, G. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.001343 · Cited by 2,399
THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses
Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U., & Presky, D. H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.495 · Cited by 1,231
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Major Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617
Depression, stress and immunological activation: The role of cytokines in depressive disorders
Connor, T. J., & Leonard, B. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)00990-9 · Cited by 482
Maes, M., Bosmans, E., Calabrese, J., Smith, R., & Meltzer, H. Y. (1995) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)00049-w · Cited by 385
Licinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380
Self-citation
Research works printed but not linked: 2
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn) American Psychiatric Press: Washington DC 1994
- First MB, Gibbon M, Spitzer RL, Williams JBW . Structural Clinical Interview for DSM-IV Research Version Biometric Research Department, New York Psychiatric Institute: New York 1998
Cited by
Items 101–200 of 227
Guenzani, D., Buoli, M., Caldiroli, L., Carnevali, G. S., Serati, M., Vezza, C., Armelloni, S., Messa, P., & Vettoretti, S. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.109783 · Cited by 54
Postolache, T. T., Lapidus, M., Sander, E. R., Langenberg, P., Hamilton, R. G., Soriano, J. J., McDonald, J. S., Furst, N., Bai, J., Scrandis, D. A., et al. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.286 · Cited by 51
“Increases in activity of TH1 cytokines, such as TNF-α have been shown to trigger depressivelike behaviors in experimental animal models [26-30] as well as decompensation of depression in humans[31].”
Inflammatory and Innate Immune Markers of Neuroprogression in Depressed and Teenage Suicide Brain
Pandey, G. N. (2017) · Modern Trends in Psychiatry · doi:10.1159/000470809 · Cited by 50
Walia, V., Chaudhary, S. K., & Kumar Sethiya, N. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2020.104939 · Cited by 51
What can post-mortem studies tell us about the pathoetiology of suicide?
Pandey, G. N., & Dwivedi, Y. (2010) · Future Neurology · doi:10.2217/fnl.10.49 · Cited by 51
“The other major evidence for a role of cytokines in the pathophysiology of depression is derived from the observations that the levels of proand/or anti-inflammatory cytokines are altered in the serum [187–201] or the CSF of depressed patients [202,203].”
BackgroundMirtazapine Inhibits Tumor Growth via Immune Response and Serotonergic System
Fang, C., Chen, H., Chiang, I., Chen, C.-C., Liao, J.-F., Su, T.-P., Chieh-Yin, T., Uchitomi, Y., & Hwang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038886 · Cited by 51
“The increased sIL12 levels in patients with major depressive disorders have been reported to be decreased after the treatment with antidepressants, including nefazodone, paroxetine, fluoxetine, sertraline, and venlafaxine [10,26].”
BackgroundGrygiel‐Górniak, B., Limphaibool, N., & Puszczewicz, M. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12826 · Cited by 50
“The levels of circulating IL12 in patients with MDD were significantly higher than those of the control group, and decreased significantly after anti-depressive treatment.(70) IFN-α affects multiple neurotransmitter systems (including dopaminergic, serotonergic, glutamatergic activity) and the functions of the frontal…”
BackgroundDíaz Sibaja, M. A., Comeche Moreno, M. I., & Mas Hesse, B. (2007) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082007001000006 · Cited by 42
Is there a common pathophysiological mechanism between COVID-19 and depression?
Lopes, L. D. S., Silva, R. O., Lima, G. D. S., Costa, A. C. D. A., de Barros, D. F., & Silva‐Néto, R. P. (2021) · Acta Neurologica Belgica · doi:10.1007/s13760-021-01748-5 · Cited by 42
Karthikeyan, S., Dimick, M. K., Fıksenbaum, L., Jeong, H., Birmaher, B. B., Kennedy, J. L., Lanctôt, K. L., LEVITT, A. J., Miller, G. E., Schaffer, A., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.11.020 · Cited by 43
Can we vaccinate against depression?
Rook, G. A. W., Raison, C. L., & Lowry, C. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.018 · Cited by 46
Szuster‐Ciesielska, A., Słotwińska, M., Stachura, A., Marmurowska-Michałowska, H., & Kandefer‐Szerszeń, M. (2004) · PubMed · Cited by 38
Shirts, B. H., Wood, J. A., Yolken, R. H., & Nimgaonkar, V. L. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30603 · Cited by 37
“In addition, treatmentwithantipsychotic medications significantly lowers serum IL-18 and IL-12 levels among schizophrenia patients [Kim et al., 2002; Lu et al., 2004].”
BackgroundRecent discoveries in dendritic cell tolerance-inducing pharmacological molecules
Švajger, U., & Rožman, P. J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106275 · Cited by 37
Immunologische Aspekte bei depressiven Störungen
Müller, N., & Schwarz, M. (2007) · Der Nervenarzt · doi:10.1007/s00115-007-2311-3 · Cited by 48
Chiang, S. S., Riedel, M., Schwarz, M., & Mueller, N. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12040 · Cited by 35
“Similarly, no significant differences were observed among the three male subgroups at the individual cytokine level (IFN-g: F(2,30) = 2.”
BackgroundResultInfluentialAnti-Inflammatory Diets and Schizophrenia
Yun, H. S., & Yang, S. J. (2020) · Clinical Nutrition Research · doi:10.7762/cnr.2020.9.4.241 · Cited by 36
“, clozapine, olanzapine, and risperidone) reduced the levels of pro-inflammatory cytokines including IL-8 and IL-12 in first episode and relapse state schizophrenia patients [36,37].”
BackgroundPae, C., Yu, H.-S., Kim, T., Lee, C., Lee, S.-J., Jun, T., Lee, C., Serretti, A., & Paik, I. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.04.004 · Cited by 39
Girardi, D., Falco, A., CARLO, A. D., Benevene, P., Comar, M., Tongiorgi, E., & Bartolucci, G. B. (2015) · Journal of Behavioral Medicine · doi:10.1007/s10865-015-9658-x · Cited by 34
“Additionally, decreased levels of IL-12 were observed in depressed patients treated with antidepressant drugs (Kim et al., 2002; Lee & Kim, 2006).”
BackgroundInflammation and Elevation of Interleukin-12p40 in Patients with Schizophrenia
Bedrossian, N., Haidar, M., Fares, J., Kobeissy, F. H., & Fares, Y. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00016 · Cited by 37
“Keywords: inflammation, biomarker, schizophrenia, IL-12p40, cytokine, interleukin, ELISA, Lebanon Frontiers in Molecular Neuroscience | www.frontiersin.org 1 March 2016 | Volume 9 | Article 16”
Yang, T., Hsu, P., Meng, M., & Su, C.-C. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0884-y · Cited by 36
“Interestingly, certain SSRIs can decrease the production of pro-inflammatory cytokines [20, 21], suppress airway inflammation in asthma patients [22], and reduce disease activity in RA patients [23].”
BackgroundOgłodek, E. A. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.08.008 · Cited by 32
Ai, A. L., Pargäment, K. I., Appel, H. B., & Kronfol, Z. (2010) · Journal of Clinical Psychology · doi:10.1002/jclp.20716 · Cited by 35
Lee, H.-Y., & Kim, Y. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.03.023 · Cited by 33
“In depression, several immune changes such as activation of the inflammatory response system and increased concentrations of proinflammatory cytokines have been reported (Maes, 1999; Leonard, 2001; Kim et al., 2002).”
Self-citationInterferon-γ down-regulates transcription of the μ-opioid receptor gene in neuronal and immune cells
Kraus, J., Börner, C., Lendeckel, U., & Höllt, V. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.07.012 · Cited by 33
“In addition to such short-term variations in Th cytokine expression, long-term imbalances, for example those associated with neurological diseases like depression and schizophrenia (Kim et al., 2002; Muller et al., 1999), could also affect μ-opioid receptor expression levels.”
BackgroundKrishna, S., Dodd, C. A., & Filipov, N. M. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.038 · Cited by 32
“the periphery, it is also possible that other peripheral inflammatory mediators (other than what we assessed), such as IL-1β or IL-12, might be contributing to the depressive behavior, as previously reported [95, 96]; this needs to be explored further.”
Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders
Debnath, M., Doyle, K., Langan, C., McDonald, C., Leonard, B., & Cannon, D. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0019-0 · Cited by 28
Long-term effect of childhood trauma: Role of inflammation and white matter in mood disorders
Poletti, S., Paolini, M., Ernst, J., Bollettini, I., Melloni, E. M. T., Vai, B., Harrington, Y. A., Bravi, B., Calesella, F., Lorenzi, C., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100529 · Cited by 32
“However, recent studies comparing MDD and BD (Bai et al., 2015; Brunoni et al., 2020; Chen et al., 2019; Kim et al., 2002; Mota et al., 2013) suggest differences in the immune activation in the two disorders with different immune/inflammatory profiles characterizing”
ResultSomatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?
Rahola, J. G. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604533 · Cited by 32
Commercialisation of Biomarker Tests for Mental Illnesses: Advances and Obstacles
Chan, M. K., Cooper, J. D., & Bahn, S. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2015.09.010 · Cited by 30
Dolsen, E. A., Soehner, A. M., & Harvey, A. G. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000529 · Cited by 29
Schuld, A., Hinze‐Selch, D., & Pollmächer, T. (2004) · Der Nervenarzt · doi:10.1007/s00115-003-1599-x · Cited by 31
Wu, M., Wang, H., Chen, Y., Lin, P., Wu, C.-K., & Tseng, P. (2016) · Medicine · doi:10.1097/md.0000000000003217 · Cited by 28
Ono, C. T., Yu, Z., Obara, T., Ishikuro, M., Murakami, K., Kikuya, M., Kikuchi, S., Kobayashi, N., Kudo, H., Ogishima, S., et al. (2023) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13566 · Cited by 26
Barichello, T., dos Santos, I., Savi, G. D., Simões, L. R., Generoso, J. S., Comim, C. M., Sachs, D., Teixeira, A. L., & Quevedo, J. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.015 · Cited by 24
Yu, Z., Jin, W., Dong, X., Ao, M., Liu, H., & Yu, L. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.104570 · Cited by 27
Wu, X., Chen, Z., Liao, Y., Yang, Z., Liang, X., Guan, N., & Gan, Z. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1063479 · Cited by 23
Sarmin, N., Roknuzzaman, A. S. M., Mouree, T. Z., Islam, M. R., & Mahmud, Z. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-51932-9 · Cited by 27
“On the other hand, those who are battling depression have been shown to exhibit increased acute inflammatory responses, which is a phenomenon that has been validated by previous research 21,23,24 .”
BackgroundResultInfluentialMicroarray Analysis of the Major Depressive Disorder mRNA Profile Data
Gao, L., Gao, Y., Xu, E., & Xie, J. M. (2015) · Psychiatry Investigation · doi:10.4306/pi.2015.12.3.388 · Cited by 24
Liu, J.-Y., Chen, H., Lin, J., Lu, M.-K., Tan, H.-P., Jang, F.-L., & Lin, S. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.38891 · Cited by 22
“Furthermore, the IL-12 concentrations were decreased in both EOS and AOS patients compared to healthy controls, the results were consistent to the previous evidence that antipsychotic drugs may suppress IL-12 concentration in psychiatric patients [29].”
ResultFree water alterations in different inflammatory subgroups in schizophrenia
Wu, D., Wu, Q., Li, F. Y., Wang, Y., Zeng, J., Tang, B., Bishop, J. R., Li, X., & Lui, S. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.11.006 · Cited by 23
Psychoneuroimmunology of Depressive Disorder: Mechanisms and Clinical Implications
Capuron, L., Miller, A. H., & Irwin, M. R. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50030-7 · Cited by 26
Nassar, A., Sharon-Granit, Y., & Azab, A. N. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.05.019 · Cited by 20
Biomarker-Guided Tailored Therapy
Lydiard, J. B., & Nemeroff, C. B. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9721-0_10 · Cited by 19
Gopalakrishnan, R., Wang, Y., Kapczinski, F. P., Frey, B. N., & Wollenhaupt-Aguiar, B. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.01.150 · Cited by 19
Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression
McCallum, R. T., & Perreault, M. L. (2021) · Cells · doi:10.3390/cells10092270 · Cited by 21
Zeng, Y., Li, W., Chen, X., You, Z., Mai, S., Lan, X., Ning, Y., & Zhou, Y. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.02.078 · Cited by 22
Matsumoto, A., Ohta, N., Goto, Y., Kashiwa, Y., Yamamoto, S., & Fujino, Y. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000606 · Cited by 19
The role of immune abnormality in depression and cardiovascular disease.
Liu, R.-H., Pan, J., Tang, X., Li, B., Liu, S., & Ma, W. (2017) · PubMed Central · doi:10.11909/j.issn.1671-5411.2017.11.006 · Cited by 21
Damri, O., Sade, Y., Toker, L., Bersudsky, Y., Belmaker, R. H., Agam, G., & Azab, A. N. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.06.012 · Cited by 19
“, 1999), reduced plasma IL-12 levels (Kim et al., 2002), and reduced IL-2, IL-2 receptor, IL-6, IL-6 receptor, IL-10 and IFNγ (Boufidou et al.”
BackgroundScoriels, L., Salek, R. M., Goodby, E., Grainger, D. J., Dean, A. M., West, J. A., Griffin, J. L., Suckling, J., Nathan, P. J., Lennox, B., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.26 · Cited by 19
Önal, H. T., Yetkin, D., & Ayaz, F. (2022) · Immunologic Research · doi:10.1007/s12026-022-09350-4 · Cited by 18
Özbey, Ü., Tuğ, E., Kara, M., & Namlı, M. N. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01798.x · Cited by 18
Holbrook, E. M., Zambrano, C. A., Wright, C. T. O., Dubé, E. M., Stewart, J. R., Sanders, W. J., Frank, M. G., MacDonald, A. S., Reber, S. O., & Lowry, C. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065176 · Cited by 19
Nahar, Z., Sal‐Sabil, N., Sohan, M., Qusar, M. S., & Islam, M. R. (2022) · Health Science Reports · doi:10.1002/hsr2.1005 · Cited by 20
“According to research that made similar conclusions to ours, MDD patients had considerably greater levels of IL‐12 than HCs, demonstrating the activation of inflammatory systems during depressive episodes.(54) A case‐control study has been carried out between 30 depressive patients and 30 controls, and it has been fou…”
ResultIn vivo immunomodulatory effects of antipsychotics on inflammatory mediators: A review
Tourjman, V., Koué, M.-È., Kouassi, É., & Potvin, S. (2012) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2012.324072 · Cited by 16
“A total of 39 studies were identified that fulfilled our inclusion criteria [8,9,13,18-21,25-56].”
BackgroundInfluentialUstekinumab for the treatment of psoriasis
Laws, P., & Warren, R. B. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.4 · Cited by 14
Cytokine changes in different types of depression: Specific or general?
Wang, H., Li, P., Zhang, Y., Zhang, C., Li, K., & Song, C. (2020) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2020.02.009 · Cited by 14
Xi, L., Zhang, Y., Han, D., & Zhang, L. (2012) · PubMed · Cited by 14
Clinical, Research and Treatment Approaches to Affective Disorders
Juruena, M. F. (2012) · InTech eBooks · doi:10.5772/1482 · Cited by 14
Flamme, A. C. L., Abernethy, D. A., Sim, D. A., Goode, L., Lockhart, M. M., Bourke, D., Milner, I., Garrill, T.-M., Joshi, P., Watson, E. C., et al. (2020) · BMJ Neurology Open · doi:10.1136/bmjno-2020-000060 · Cited by 14
“[3, 4] Given the known role for neuroinflammation in schizophrenia,[5-7] it is now believed that this class of agents may provide superior benefits during schizophrenia due to their immune-modulatory activity in the CNS.”
BackgroundChan, M. K., Cooper, J. D., Bot, M., Steiner, J., Penninx, B. W. J. H., & Bahn, S. (2015) · Neuroendocrinology · doi:10.1159/000442208 · Cited by 18
Wang, Q., Zhong, Y., Chen, N., & Chen, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1078984 · Cited by 12
“One study detected high level of IL-12 in the peripheral blood of MDD patients, but IL-12 levels decreased after treatment (Kim et al., 2002).”
BackgroundYirun, M. C., Yirün, O., Ünal, K., Yüksel, R. N., Altunsoy, N., YAYLACI, E. T., Aydemır, M. Ç., & Göka, E. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.07.067 · Cited by 14
“1994), and though two recent studies (Chorianopoulos et al., 2010; Koçak et al., 2012) focusing on TWEAK did not report a relationship between smoking status and TWEAK levels, all findings about TWEAK and nicotine consumption remain highly premature.”
BackgroundFiedorowicz, J. G., Cyranowski, J. M., Liu, Z., & Swartz, H. A. (2019) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2019.07.007 · Cited by 11
“, 2006; Rapaport, 1994), included diagnoses other than bipolar disorder (Hung et al., 2007; Kim et al., 2002; Maes, Bosmans, Calabrese, Smith, & Meltzer, 1995; Su et al., 2011), or did not specify bipolar subtype (O’Brien, Scully, Scott, & Dinan, 2006; Rapaport, Guylai, & Whybrow, 1999).”
Effects of olanzapine on LPS-induced inflammation in rat primary glia cells
Faour-Nmarne, C., & Azab, A. N. (2015) · Innate Immunity · doi:10.1177/1753425915613425 · Cited by 12
Boller, A.-L., Ruland, T., Dantas, R. L., Michels, S., Dannlowski, U., Scheu, S., Baune, B. T., Culmsee, C., & Alferink, J. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.07.004 · Cited by 10
“Since DC-derived IL-12 promotes Th1 responses, LTCC-mediated effects on IL-12 production by DCs may promote neuroinflammatory pathways linked to mental disorders (Kim et al., 2002) and ASD.”
SNP Data Science for Classification of Bipolar Disorder I and Bipolar Disorder II
Lee, C., Zeng, J.-H., Lee, S.-Y., Lu, R., & Kuo, P. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.2988024 · Cited by 10
Oud, L., & Garza, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265240 · Cited by 13
“These associations between pre-sepsis immune dysfunction and mortality are supported by studies showing that sepsis impairs production of IL-1, IL-6, TNF-α [67], IL-12 [68], and IFN-γ [69] and suggesting that this sepsis-induced immunosuppressive state may be augmented by release of IL-4 and IL-10 [69].”
BackgroundInfluentialZou, W., Zhang, K., Qiu, Z., Xin, R., Wang, G., Zhang, J., & Li, J. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113584 · Cited by 11
Francesconi, L. P., Victorino, A. T., Salah, I. A., Cordova, V. H. S., da Rosa, E. D., de Oliveira, L. B., Jacobus, R. V., Belmonte-de-Abreu, P. S., & Ceresér, K. M. (2018) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000241 · Cited by 11
Freff, J., Beins, E. C., Bröker, L., Schwarte, K., Dantas, R. L., Maj, C., Arolt, V., Dannlowski, U., Nöthen, M. M., Baune, B. T., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.05.003 · Cited by 9
Inflammation, depression and atherosclerosis or depression, inflammation and atherosclerosis?
Raggi, P. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.07.902 · Cited by 9
Jacques, C., & Floris, I. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s389614 · Cited by 8
Rothermundt, M., & Arolt, V. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50033-2 · Cited by 8
Interleukin-6 and Hospital Length of Stay after Open-heart Surgery.
Ai, A. L., Hall, D. E., & Bolling, S. F. (2012) · PubMed · Cited by 10
Cytokines, Immunity and Schizophrenia with Emphasis on Underlying Neurochemical Mechanisms
Müller, N., & Schwarz, M. (2008) · Springer eBooks · doi:10.1007/978-0-387-84851-8_15 · Cited by 7
Imunologia do transtorno bipolar
Barbosa, I. G., Huguet, R. B., Neves, F. S., Bauer, M. E., & Teixeira, A. L. (2009) · Jornal Brasileiro de Psiquiatria · doi:10.1590/s0047-20852009000100009 · Cited by 6
Exploration of Biological Markers of Suicidal Behavior in Major Depressive Disorder
Kim, Y. K., Won, S.-D., Hur, J., Lee, B. H., Lee, H. Y., Shim, S. H., Han, S. W., & Choi, S. H. (2007) · Psychiatry Investigation · Cited by 7
Self-citationMajor depressive disorder (mdd): emerging immune targets at preclinical level
Varma, M., Kaur, A., Bhandari, R., Kumar, A., & Kuhad, A. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2225216 · Cited by 6
“In general, IL−1 has long been known to be among the most active and potent cytokines, stimulating the production of IFN-γ and TNF-α along with its own expression [88].”
BackgroundResultInfluentialPeters, E. M. J., Neusetzer, M., Akinci, S., Murat, A., Treuherz, S., Rose, M., Leweke, F., Leichsenring, F., Conrad, M. L., & Kruse, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.571636 · Cited by 7
Putative biological predictors of treatment response in bipolar disorders
Gonzalez, S., Williams, A. J., Blacker, C. J., Voort, J. L. V., Schak, K. M., Nemeroff, C. B., Widge, A. S., & Tohen, M. F. (2016) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2016.11.003 · Cited by 6
“This same group found that IL-12 levels also decreased significantly for those with bipolar disorder after 8 weeks of either lithium or valproate sodium [139].”
Backgrounddortaj, A., Aliakbar Dehkordi, M., Naser moghadasi, A., & Alipour, A. (2021) · Journal of Applied Psychology · doi:10.52547/apsy.2021.216250.0 · Cited by 4
Saitoh, K., Sugusabesan, S., Lajnef, M., Lamy, A., Boukouaci, W., Wu, C., Bouassida, J., Richard, J., Corvoisier, P. L., Barau, C., et al. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100754 · Cited by 4
Ozer, E. A., Keskin, A., Berrak, Y. H., Cankara, F., Can, F., Özdemir, Y., Keskin, Ö., Gürsoy, A., & Eser, H. Y. (2025) · Discover Mental Health · doi:10.1007/s44192-025-00128-2 · Cited by 4
Peripheral Biological Markers for Mood Disorders
Pandey, G. N., & Dwivedi, Y. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9838-3_9 · Cited by 3
Immunomodulatory effects of amisulpride on mammalian macrophages
Gürcan, M. B., Gürcan, N. E., Özarslan, F. S., Gökçe, B. B., Özpamukçu, B. N., Aydemir, E., & Ayaz, F. (2025) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-025-04188-9 · Cited by 4
Cytokines and the Immune–Neuroendocrine Network
Correa, S. G., Sotomayor, C. E., & Rodriguez‐Galán, M. C. (2010) · Neuroimmune biology · doi:10.1016/s1567-7443(10)70012-0 · Cited by 3
Depression and cytokines from evolutionary perspective
Doksat, M. K. (2003) · Psychiatry and Clinical Psychopharmacology · Cited by 9
Stress, Inflammation and Neurogenesis in Major Depression
Kim, Y. K. (2011) · Cited by 3
Self-citationLaws, P., Young, H. S., & Warren, R. B. (2014) · Springer eBooks · doi:10.1007/978-1-4471-4432-8_21 · Cited by 3
“A common pathogenic pathway for psoriasis and depression may involve IL-12 which is elevated in depression and is also a key cytokine established in the pathogenesis of psoriasis [ 135 , 136 ].”
BackgroundFirst-onset postpartum psychosis
Bergink, V. (2012) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 6
Stern, L., Agam, G., Shvartsur, R., Alhoashla, A., Tailakh, M. A., & Azab, A. N. (2026) · Pharmaceuticals · doi:10.3390/ph19030435 · Cited by 2
Cytokines, Behavior, and Affective Disorders
Vellucci, S. V. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384691-4.00012-2 · Cited by 2
The effect of drugs used in allergic rhinitis on the central nervous system
Walkiewicz, G., Jankowska, M., & Pawliczak, R. (2020) · Alergologia Polska - Polish Journal of Allergology · doi:10.5114/pja.2020.102085 · Cited by 2
Natural molecules in the treatment of schizophrenia
Munawar, N., Ahsan, K., & Ahmad, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00011-7 · Cited by 2
Immunity and Depression: A Clinical Perspective
Schleifer, S. J. (2008) · Springer eBooks · doi:10.1007/978-0-387-84851-8_14 · Cited by 2
Biological Prediction of Suicidal Behavior in Patients with Major Depressive Disorder
Kim, Y. (2012) · InTech eBooks · doi:10.5772/32269 · Cited by 2
“Pro-inflammatory cytokines including IL-1, IL-6, IL-12, and TNF- are increased in the blood in major depression (Kim et al. 2002b; Thomas et al. 2005; Tuglu et al. 2003; Viljoen and Panzer 2005).”
BackgroundSelf-citationProteomic Studies of Psychiatric Disorders
Guest, P. C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7614-0_4 · Cited by 3
Laws, P., & Warren, R. B. (2020) · Springer eBooks · doi:10.1007/978-3-030-54859-9_27 · Cited by 2
Metadata
- Authors
- Kim, Y.-K., Suh, I.-B., Kim, H., Han, C.-S., Lim, C.-S., Choi, S.-H., & Licinio, J.
- Affiliations
- Korea University Ansan Hospital (KR)
- Korea University (KR)
- Yongin Mental Hospital (KR)
- University of California, Los Angeles (US)
- Corresponding author
- Kim, H
- ORCID
- Venue
- Molecular Psychiatry
- Published
- 2002-12-01
- Volume
- 7
- Issue
- 10
- Pages
- 1107-1114
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1992868687
- Cited by
- 224
- References
- 62
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 6 · 2022: 9 · 2021: 7 · 2020: 16 · 2019: 8 · 2018: 5 · 2017: 9 · 2016: 17 · 2015: 14 · 2014: 12 · 2013: 9 · 2012: 19
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- IL-12, schizophrenia, major depressive disorder, bipolar mania, psychotropic drugs, antidepressants, antipsychotic drugs, cytokines, Th1 response, plasma cytokines
- MeSH terms
- Adolescent, Adult, Aged, Bipolar Disorder, Depressive Disorder, Female, Humans, Male, Middle Aged, Psychotropic Drugs, Reference Values, Schizophrenia, Th1 Cells, Interleukin-12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.